March 2021
264 articles-
Mar 31 · 12:19Biotechnology Daily
Butterfly Network, with its transformation complete, seeks new clinical, payer collabs
-
Mar 31 · 12:18Biotechnology Daily
Novartis bolsters radioligand stable with iTheranostics deal
-
Mar 31 · 12:16Biotechnology Daily
Forma builds case for FT-4202 in competitive sickle cell space
-
Mar 31 · 12:15Biotechnology Daily
Taking gene therapy to the masses with innovations in diabetes, Alzheimer's and more
-
Mar 31 · 12:12Bio Business News
After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B
-
Mar 31 · 12:07Bio Business News
Omega grabs $126M to bring 'genome-tuning' cancer treatment into the clinic
-
Mar 31 · 12:01Bio Business News
Merck sets up $240M Alydia Health buyout to beef up its future Organon women's health spinout
-
Mar 31 · 11:57Bio Business News
Wave culls leading Huntington's meds as shares go under after rival Roche hit by similar fate
-
Mar 31 · 11:20Market Watch
BlackBerry stock falls as revenue comes up short amid patent-sale negotiations
-
Mar 31 · 11:18Market Watch
U.S. stock futures mixed as investors await Biden infrastructure plan
-
Mar 31 · 11:03Market Watch
UBS upgrades Apple to buy on auto market hopes
-
Mar 31 · 10:43Market Watch
Goldman to offer bitcoin and other crypto to wealthy investors
-
Mar 30 · 10:13Biotechnology Daily
Could a single pill treat a tumor today and head off its drug resistance mechanisms tomorrow? ResistanceBio is on the case
-
Mar 30 · 10:11Biotechnology Daily
Orphazyme shares sink as late-stage test of 'heat shock protein' flops
-
Mar 30 · 10:10Biotechnology Daily
Speeding past patient access barriers to deliver therapies in a post-pandemic world
-
Mar 30 · 10:07Biotechnology Daily
Boston Scientific pads case for radioactive microspheres with liver cancer survival win
-
Mar 30 · 10:06Bio Business News
Medtronic’s transcatheter pulmonary heart valve nets world-first approval from FDA
-
Mar 30 · 10:04Bio Business News
NK Disruptor GT Biopharma Advances Liquid and Solid Tumor Cancer TriKEs in Clinical Development
-
Mar 30 · 10:02Bio Business News
Ionis' antisense drug curbs HAE attacks in phase 2
-
Mar 30 · 10:00Bio Business News
UniQure gene therapy 'highly unlikely' to be liver cancer trigger
-
Mar 30 · 09:43Market Watch
McCormick stock gains after earnings beat
-
Mar 30 · 09:38Market Watch
Bitcoin climbs as PayPal launches 'Checkout with Crypto'
-
Mar 30 · 09:29Market Watch
U.S. stock futures under pressure as bond yields resume rise
-
Mar 29 · 04:05Biotechnology Daily
Enhancing CAR-T therapy by leveraging its communication with the immune system